Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A crossover comparison of glycemic variations in Japanese patients with type 1 diabetes receiving insulin glargine versus insulin detemir twice daily using continuous glucose monitoring (CGM): J COLLECTION (Jikei COmparison of Lantus and LEvemir with Cgm for Thinking Insulin OptimizatioN).
Tsujino D, Nishimura R, Morimoto A, Tajima N, Utsunomiya K. Tsujino D, et al. Diabetes Technol Ther. 2012 Jul;14(7):596-601. doi: 10.1089/dia.2011.0235. Diabetes Technol Ther. 2012. PMID: 22775404
Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin glargine using continuous glucose monitoring: A randomized, cross-over, pilot study.
Onda Y, Nishimura R, Ando K, Takahashi H, Tsujino D, Utsunomiya K. Onda Y, et al. Among authors: tsujino d. Diabetes Res Clin Pract. 2016 Oct;120:149-55. doi: 10.1016/j.diabres.2016.07.019. Epub 2016 Aug 6. Diabetes Res Clin Pract. 2016. PMID: 27562434 Clinical Trial.
Which is better, high-dose metformin monotherapy or low-dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insufficient glycemic control despite low-dose metformin monotherapy? A randomized, cross-over, continuous glucose monitoring-based pilot study.
Takahashi H, Nishimura R, Tsujino D, Utsunomiya K. Takahashi H, et al. Among authors: tsujino d. J Diabetes Investig. 2019 May;10(3):714-722. doi: 10.1111/jdi.12922. Epub 2018 Oct 9. J Diabetes Investig. 2019. PMID: 30171747 Free PMC article. Clinical Trial.
Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: a comparative pilot study -results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study.
Nishimura R, Tsujino D, Taki K, Morimoto A, Tajima N. Nishimura R, et al. Among authors: tsujino d. Cardiovasc Diabetol. 2010 May 3;9:16. doi: 10.1186/1475-2840-9-16. Cardiovasc Diabetol. 2010. PMID: 20438630 Free PMC article. Clinical Trial.
Low prevalence of metabolic syndrome and its components in rural Japan.
Morimoto A, Nishimura R, Suzuki N, Matsudaira T, Taki K, Tsujino D, Miyashita Y, Ebara F, Ishikawa S, Tajima N. Morimoto A, et al. Among authors: tsujino d. Tohoku J Exp Med. 2008 Sep;216(1):69-75. doi: 10.1620/tjem.216.69. Tohoku J Exp Med. 2008. PMID: 18719340 Free article.
51 results